Sepsis-Associated Acute Kidney Injury
Pathophysiology and Clinical Presentation
- The metabolic hallmark of AKI in sepsis includes protein catabolism, altered amino acid metabolism, peripheral insulin resistance, and impaired lipid clearance, typically resulting in metabolic acidosis 1, 2
- Tissue hypoperfusion leads to lactic acidosis, a common acid-base disturbance in sepsis-associated AKI 3
- Impaired renal acid excretion due to kidney dysfunction contributes to metabolic acidosis in sepsis-associated AKI 4
- Inflammatory mediators affect cellular metabolism, leading to metabolic derangements and acidosis in sepsis-associated AKI 5
Management and Treatment
- The KDIGO guidelines address the management of metabolic acidosis in AKI, indicating its prevalence in this condition 4, 6
- The Surviving Sepsis Campaign guidelines recommend against the use of sodium bicarbonate therapy for hypoperfusion-induced lactic acidemia with pH ≥ 7.15 3
- Management of sepsis-associated AKI should focus on treating the underlying sepsis with appropriate antimicrobials, maintaining adequate renal perfusion, and using crystalloids rather than colloids for fluid resuscitation 3, 4
- Renal replacement therapy should be considered for severe metabolic derangements in sepsis-associated AKI 3
Monitoring and Prevention
- Regular monitoring of acid-base status is essential in patients with sepsis-associated AKI 3
- Prevention strategies should focus on early recognition and treatment of sepsis, avoiding nephrotoxic medications, maintaining adequate renal perfusion, and appropriate fluid management to prevent both hypovolemia and fluid overload 4, 7